Breakthrough self-collection technology offers women a more comfortable, accessible alternative to traditional in-clinic screenings, aiming to boost early detection and public health outcomes. ...
NIH-backed study validates FDA-cleared diagnostic transport medium as a critical tool for safe virus handling and global biosurveillance....
Final approval clears the way for Zydus to market Glatiramer Acetate, expanding access to a key treatment for multiple sclerosis patients in the U.S. ...
Award Highlights Glytec’s Leadership in Advancing Safe, Effective Insulin Management Through Innovative Software Solutions...
New Liquid Biopsy Technology Offers Hope in Diagnosing One of the Deadliest Cancers at an Early Stage...
Series B1 Funding to Scale AI-Powered Data Abstraction and Analytics Across U.S. Healthcare Systems...
New Fibrosis Biomarker Enhances Diagnostic Capabilities for Chronic Liver Disease Across Global Labs...
Innovative platform streamlines sample-to-result diagnostics, offering scalable, multiplexed solutions for global clinical laboratories....
Personalized iPSC-derived dopaminergic neuron therapy shows early signs of safety and potential benefit in first-in-human study...
Next-generation ecosystem enhances treatment adherence, remote monitoring, and personalized support for patients with growth hormone disorders....
![[L-R]: Ms. Vivien Tan, XP Business Manager, Siemens Healthineers ASEAN; Prof. Dr. dr. Lina Choridah, Sp.Rad (K), Chairwoman Indonesian Woman Imaging Society; Hendya Perbangkara, Head of Diagnostic Imaging, Siemens Healthineers Indonesia](/uploads/articles/l_r__ms_vivien_tan_xp_business_manager_siemens_healthineers_asean-24188.jpg)
